Drug Type Small molecule drug |
Synonyms KA-7 |
Target |
Action agonists |
Mechanism KDM3B agonists(lysine demethylase 3B agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute leukemia | Preclinical | - | - | 29 Nov 2018 |